Fust Matthew K - Insider Non-Derivative Transactions at Crinetics Pharmaceuticals, Inc. (CRNX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 7, 2024, Fust Matthew K's relationship to Crinetics Pharmaceuticals, Inc. (CRNX) is Director, and currently has 21,936 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other CRNX insiders.
Data Source: SEC.
Fust Matthew K - Insider Non-Derivative Transactions of CRNX Common Stock
Fust Matthew K - Insider Non-Derivative Transactions at CRNX
Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 8, 2024 | Acquisition -- (Common Stock) | 3,400 | 0 | 21,936 |
| Mar 21, 2024 | Sell -- (Common Stock) | 12,500 | 43.57 | 18,536 |
| Mar 21, 2024 | Sell -- (Common Stock) | 17,500 | 45.5 | 18,536 |
| Mar 21, 2024 | Sell -- (Common Stock) | 17,500 | 43.58 | 18,536 |
| Mar 21, 2024 | M -- (Common Stock) | 12,500 | 23.23 | 31,036 |
| Mar 21, 2024 | M -- (Common Stock) | 12,500 | 23.24 | 31,036 |
| Mar 21, 2024 | M -- (Common Stock) | 17,500 | 18.29 | 36,036 |
| Mar 21, 2024 | M -- (Common Stock) | 17,500 | 20.23 | 36,036 |
| Jun 17, 2023 | Acquisition -- (Common Stock) | 6,000 | 0 | 18,536 |
Items per page:
1 – 9 of 9